Neurosciences Imaging Group, Molecular Imaging Centre (CRC-CIM), Barcelona Biomedical Research Park, C/ Dr. Aiguader 88, soterrani-1, 08003 Barcelona, Spain.
Neuroimage. 2010 May 1;50(4):1511-8. doi: 10.1016/j.neuroimage.2010.01.013. Epub 2010 Jan 18.
Reported values of D(2) receptor occupancy (RO) achieved by antipsychotic drugs tend to be lower when measured with (123)I-IBZM SPECT than with (11)C-Raclopride PET. Image degrading factors such as attenuation, distance-dependent collimator response and scatter could account for this difference. While attenuation correction is routinely applied to SPECT images, the other degradations are not usually accounted for. The aim of this work was to assess the impact of scatter correction on D(2) RO quantification with (123)I-IBZM SPECT, and to compare the results of both corrected and un-corrected SPECT values with (11)C-Raclopride PET measurements. Phantom experiments as well as within-subject human data from a previous study were used for this purpose. SPECT images were reconstructed using filtered back-projection including attenuation correction (FBP(A)), ordered subsets expectation maximization including attenuation and point spread function corrections (OSEM(A+PSF)) and ordered subsets expectation maximization including attenuation, point spread function and scatter corrections (OSEM(A+PSF+SCT)). PET images were reconstructed using the FBP algorithm and corrected for attenuation, scatter, random coincidences and dead time. Quantification of receptor availability was performed using the tissue ratio at pseudoequilibrium for SPECT, and the simplified reference tissue model (SRTM) for PET. Analysis was performed using both occipital cortex (occ) and cerebellum (cer) as reference regions for both modalities. When images were reconstructed using FBP(A), SPECT D(2) RO values were significantly lower as compared with PET leading to a D(2) RO difference of -20% (CI(95%): -13, -27%) (occ) and -23% (CI(95%): -14, -31%) (cer). When images were reconstructed using OSEM(A+PSF), SPECT D(2) RO values were also lower as compared with PET leading to a D(2) RO difference of -21% (CI(95%): -14, -27%) (occ) and -24% (CI(95%): -18, -30%) (cer). When images were reconstructed using OSEM(A+PSF+SCT), the D(2) RO bias was reduced to -6% (CI(95%): 0, -13%) (occ) and -11% (CI(95%): -4, -18%) (cer). These data suggest that the scatter correction plays a major role in explaining the differences between D(2) RO measurements using (123)I-IBZM SPECT and (11)C-Raclopride PET.
报告的抗精神病药物 D2 受体占有率 (RO) 值在使用 (123)I-IBZM SPECT 测量时往往低于使用 (11)C-racopride PET 测量时。图像退化因素,如衰减、距离依赖性准直器响应和散射,可能导致这种差异。虽然衰减校正通常应用于 SPECT 图像,但其他退化因素通常不考虑。本工作的目的是评估散射校正对 (123)I-IBZM SPECT 中 D2 RO 定量的影响,并比较校正和未校正 SPECT 值与 (11)C-racopride PET 测量结果。为此目的,使用了来自先前研究的体模实验和受试者内数据。SPECT 图像使用包括衰减校正的滤波反投影重建 (FBP(A))、包括衰减和点扩散函数校正的有序子集期望最大化重建 (OSEM(A+PSF)) 和包括衰减、点扩散函数和散射校正的有序子集期望最大化重建 (OSEM(A+PSF+SCT))。使用 FBP 算法重建 PET 图像,并校正衰减、散射、随机巧合和死时间。使用 SPECT 的组织比在假性平衡时和 PET 的简化参考组织模型 (SRTM) 进行受体可用性的定量。使用两种模态的枕叶皮层 (occ) 和小脑 (cer) 作为参考区域进行分析。当使用 FBP(A) 重建图像时,与 PET 相比,SPECT D2 RO 值显著降低,导致 D2 RO 差异为-20%(CI(95%):-13,-27%)(occ)和-23%(CI(95%):-14,-31%)(cer)。当使用 OSEM(A+PSF) 重建图像时,与 PET 相比,SPECT D2 RO 值也较低,导致 D2 RO 差异为-21%(CI(95%):-14,-27%)(occ)和-24%(CI(95%):-18,-30%)(cer)。当使用 OSEM(A+PSF+SCT) 重建图像时,D2 RO 偏差减少到-6%(CI(95%):0,-13%)(occ)和-11%(CI(95%):-4,-18%)(cer)。这些数据表明,散射校正对解释使用 (123)I-IBZM SPECT 和 (11)C-racopride PET 测量的 D2 RO 值之间的差异起着重要作用。